Description
PHARMACEUTICAL - PENTETATE CALCIUM & ZINC
First action · last action
2024-07-31 · 2024-07-31
Transactions
1
First transaction's obligation
$1,004,500
Base + all options value (sum of deltas)
$1,004,500
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-07-31+$1,004,500= $1,004,500
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-07-31 | +$1,004,500 | $1,004,500 | PHARMACEUTICAL - PENTETATE CALCIUM & ZINC |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GQLDJJ8AQNN5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79726D0041 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0042 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0022 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0014 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0023 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0018 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6515 from NATIONAL CMOP OFFICE (36C770) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C77026N0048 | MERZ PHARMACEUTICALS, LLC | NATIONAL CMOP OFFICE (36C770) | $236,612 | FY2026 |
| 36C77026K0041 | ALPHAPOINTE | NATIONAL CMOP OFFICE (36C770) | $993,585 | FY2026 |
| 36C77026P0104 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $17,964 | FY2026 |
| 36C77026F0045 | ATOS MEDICAL INC | NATIONAL CMOP OFFICE (36C770) | $513,331 | FY2026 |
| 36C77026K0040 | ALPHAPOINTE | NATIONAL CMOP OFFICE (36C770) | $1,505,645 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C77024P0293_3600_-NONE-_-NONE- · retrieved 2026-09-26.